RECURSION PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Gibson Christopher | Chief Executive Officer | Award / Grant | 16,809 | — | — | 1,278,725 | Feb 3, 2025 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $7.31 | $146,200 | 736,633 | Jan 8, 2025 |
| Dar Zavain | — | Award / Grant | 1,907 | — | — | 108,132 | Jan 2, 2025 |
| Li Dean Y | — | Award / Grant | 1,647 | — | — | 77,350 | Jan 2, 2025 |
| Borgeson Blake | — | Award / Grant | 1,734 | — | — | 7,067,847 | Jan 2, 2025 |
| Taylor Ben R | Chief Financial Officer | Award / Grant | 370,343 | — | — | 844,210 | Dec 19, 2024 |
| Taylor Ben R | Chief Financial Officer | Tax Withholding | 15,668 | $6.04 | $94,635 | 480,924 | Dec 17, 2024 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $7.16 | $143,200 | 736,633 | Dec 4, 2024 |
| Michor Franziska | — | Award / Grant | 41,390 | — | — | 105,037 | Nov 20, 2024 |
| Mauro David J | Chief Medical Officer | Tax Withholding | 4,187 | $6.18 | $25,876 | 225,429 | Nov 15, 2024 |
| Secora Michael | Chief Financial Officer | Tax Withholding | 11,937 | $6.18 | $73,771 | 1,487,694 | Nov 15, 2024 |
| Marriott Tina | President and COO | Tax Withholding | 14,286 | $6.18 | $88,287 | 506,852 | Nov 15, 2024 |
| Gibson Christopher | Chief Executive Officer | Tax Withholding | 26,023 | $6.18 | $160,822 | 736,633 | Nov 15, 2024 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $7.74 | $154,800 | 762,656 | Nov 14, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $7.64 | $87,455 | 7,066,113 | Nov 12, 2024 |
| Secora Michael | Chief Financial Officer | Sale | 15,000 | $7.64 | $114,600 | 1,475,256 | Nov 12, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.72 | $76,924 | 7,077,560 | Oct 29, 2024 |
| Marriott Tina | President and COO | Option Exercise | 6,000 | $1.06 | $6,360 | 527,138 | Oct 24, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.67 | $76,351 | 7,089,007 | Oct 15, 2024 |
| Secora Michael | Chief Financial Officer | Sale | 15,000 | $6.36 | $95,400 | 1,450,881 | Oct 9, 2024 |
| Gibson Christopher | Chief Executive Officer | C | 20,000 | — | — | 782,656 | Oct 3, 2024 |
| Borgeson Blake | — | Award / Grant | 2,026 | — | — | 7,100,454 | Oct 1, 2024 |
| Dar Zavain | — | Award / Grant | 2,229 | — | — | 106,225 | Oct 1, 2024 |
| Li Dean Y | — | Award / Grant | 1,925 | — | — | 75,703 | Oct 1, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.22 | $71,200 | 7,098,428 | Oct 1, 2024 |
| Marriott Tina | President and COO | Option Exercise | 6,000 | $1.06 | $6,360 | 527,138 | Sep 26, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.84 | $78,297 | 7,109,875 | Sep 17, 2024 |
| Secora Michael | Chief Financial Officer | Option Exercise | 39,375 | $2.22 | $87,413 | 1,392,756 | Sep 11, 2024 |
| Gibson Christopher | Chief Executive Officer | Sale | 20,000 | $6.14 | $122,800 | 762,656 | Sep 5, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.27 | $71,773 | 7,121,322 | Sep 3, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 762,656 | Aug 30, 2024 |
| Marriott Tina | President and COO | Sale | 6,000 | $7.56 | $45,360 | 521,138 | Aug 29, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 757,656 | Aug 29, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 752,656 | Aug 28, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 747,656 | Aug 27, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 742,656 | Aug 26, 2024 |
| Gibson Christopher | Chief Executive Officer | Option Exercise | 5,000 | $2.48 | $12,400 | 737,656 | Aug 23, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $7.12 | $81,503 | 7,132,769 | Aug 20, 2024 |
| Marriott Tina | President and COO | Tax Withholding | 14,319 | $6.69 | $95,794 | 521,138 | Aug 15, 2024 |
| Mauro David J | Chief Medical Officer | Tax Withholding | 14,146 | $6.69 | $94,637 | 229,616 | Aug 15, 2024 |
| Gibson Christopher | Chief Executive Officer | Tax Withholding | 26,082 | $6.69 | $174,489 | 732,656 | Aug 15, 2024 |
| Secora Michael | Chief Financial Officer | Tax Withholding | 11,962 | $6.69 | $80,026 | 1,353,381 | Aug 15, 2024 |
| Secora Michael | Chief Financial Officer | Sale | 15,000 | $6.35 | $95,250 | 1,340,968 | Aug 13, 2024 |
| Gibson Christopher | Chief Executive Officer | Sale | 30,000 | $7.10 | $213,000 | 758,738 | Aug 7, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $6.82 | $78,069 | 7,144,216 | Aug 6, 2024 |
| Khan Najat | Chief R&D Commercial Officer | Award / Grant | 496,972 | — | — | 496,972 | Aug 1, 2024 |
| Marriott Tina | President and COO | Sale | 6,000 | $8.13 | $48,780 | 535,457 | Jul 25, 2024 |
| Borgeson Blake | — | Sale | 11,447 | $8.48 | $97,071 | 7,155,663 | Jul 23, 2024 |
| Gibson Christopher | Chief Executive Officer | C | 50,000 | — | — | 808,738 | Jul 11, 2024 |
| Secora Michael | Chief Financial Officer | Sale | 15,000 | $7.24 | $108,600 | 1,316,593 | Jul 9, 2024 |